Efficacy and safety of sequential versus quadruple therapy as second-line treatment for helicobacter pylori infection—A randomized controlled trial

Helicobacter Pylori ◽

Controlled Trial ◽

Line Treatment ◽

Second Line ◽

Efficacy And Safety ◽

Quadruple Therapy ◽

Su1281 – Tetracycline-Levofloxacin Quadruple Therapy Achieves a Higher Eradication Rate Than Amoxicillin-Levofloxacin Quadruple Therapy in the Second-Line Treatment of Helicobacter Pylori Infection — a Randomized Controlled Trial

Gastroenterology ◽

10.1016/s0016-5085(19)38206-x ◽

2019 ◽

Vol 156 (6) ◽

pp. S-529

Author(s):

Ping-I Hsu ◽

Deng-Chyang Wu ◽

Consortium Taiwan Acid-Related Disease and Microbiota (TARD-M)

Keyword(s):

Helicobacter Pylori ◽

Eradication Rate ◽

Controlled Trial ◽

Line Treatment ◽

Second Line ◽

Quadruple Therapy ◽

Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial

Wiener klinische Wochenschrift ◽

10.1007/s00508-008-1122-2 ◽

2009 ◽

Vol 121 (1-2) ◽

pp. 47-52 ◽

Cited By ~ 15

Author(s):

Josip Bago ◽

Branko Pevec ◽

Monika Tomić ◽

Marinko Marušić ◽

Vinko Bakula ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

Line Treatment ◽

Second Line ◽

Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial

The American Journal of Gastroenterology ◽

10.1038/ajg.2017.195 ◽

2017 ◽

Vol 112 (9) ◽

pp. 1374-1381 ◽

Cited By ~ 14

Author(s):

Ping-I Hsu ◽

Feng-Woei Tsai ◽

Sung-Shuo Kao ◽

Wen-Hung Hsu ◽

Jin-Shiung Cheng ◽

...

Keyword(s):

Helicobacter Pylori ◽

Proton Pump Inhibitor ◽

Triple Therapy ◽

Proton Pump ◽

Controlled Trial ◽

Line Treatment ◽

Second Line ◽

Quadruple Therapy ◽

Proton Pump Inhibitor-Bismuth-Tetracycline-Levofloxacin Quadruple Therapy Achieves a Higher Eradication Rate than Standard Levofloxacin-Containing Triple Therapy in the Second-Line Treatment of Helicobacter Pylori Infection and a Randomized Controlled Trial

Gastroenterology ◽

10.1016/s0016-5085(17)31116-2 ◽

2017 ◽

Vol 152 (5) ◽

pp. S247

Author(s):

Sung-Shuo Kao ◽

Deng-Chyang Wu ◽

Feng-Woei Tsay Tsay ◽

Kuo-Wang Tsai ◽

Ping-I Hsu

Keyword(s):

Helicobacter Pylori ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Eradication Rate ◽

Controlled Trial ◽

Line Treatment ◽

Second Line ◽

Quadruple Therapy ◽

Susceptibility‐guided quadruple therapy is not superior to medication history‐guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trial

Journal of Digestive Diseases ◽

10.1111/1751-2980.12934 ◽

2020 ◽

Vol 21 (10) ◽

pp. 549-557

Author(s):

Chao Ran Ji ◽

Jing Liu ◽

Yue Yue Li ◽

Chen Qiao ◽

Jun Yan Qu ◽

...

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

Medication History ◽

Quadruple Therapy ◽

Randomized Controlled ◽

Rescue Treatment ◽

Guided Therapy

Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial

Medicine ◽

10.1097/md.0000000000013245 ◽

2018 ◽

Vol 97 (46) ◽

pp. e13245 ◽

Cited By ~ 2

Author(s):

Hyun Lim ◽

Chang Seok Bang ◽

Woon Geon Shin ◽

Jae Ho Choi ◽

Jae Seung Soh ◽

...

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

Line Treatment ◽

First Line ◽

Open Label ◽

Quadruple Therapy ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial ◽

First Line Treatment

Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-017-2281-0 ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 4

Author(s):

Hyuk Lee ◽

◽

Beom Jin Kim ◽

Sang Gyun Kim ◽

Jin Il Kim ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Study Protocol ◽

Controlled Trial ◽

Line Treatment ◽

First Line ◽

Randomized Controlled ◽

First Line Treatment

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

Alimentary Pharmacology & Therapeutics ◽

10.1046/j.1365-2036.2003.01459.x ◽

2003 ◽

Vol 17 (4) ◽

pp. 553-560 ◽

Cited By ~ 93

Author(s):

W. M. Wong ◽

Q. Gu ◽

S. K. Lam ◽

F. M. Y. Fung ◽

K. C. Lai ◽

...

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Randomized Controlled Study ◽

Controlled Study ◽

Line Treatment ◽

Second Line ◽

Quadruple Therapy ◽

Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dks361 ◽

2012 ◽

Vol 68 (1) ◽

pp. 222-228 ◽

Cited By ~ 32

Author(s):

C.-H. Kuo ◽

P.-I. Hsu ◽

F.-C. Kuo ◽

S. S. W. Wang ◽

H.-M. Hu ◽

...

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

High Dose ◽

Second Line ◽

Quadruple Therapy ◽

Faculty Opinions recommendation of Comparison of 10 day bismuth quadruple therapy with high-dose metronidazole or levofloxacin for second-line Helicobacter pylori therapy: a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958698.793463933 ◽

2012 ◽

Author(s):

Direk Limmathurotsakul

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

High Dose ◽

Second Line ◽

Quadruple Therapy ◽